Suryoday Small Finance Bank to Raise Capital via NCDs to Meet Basel II Requirements
What happened
Suryoday Small Finance Bank Limited announced that its Board of Directors approved a capital raise through Non-Convertible Debentures (NCDs) to meet Basel II requirements. The overall raising of capital through NCDs was approved up to ₹400 Crores in one or more tranches. Specifically, the Board granted approval for a single tranche of up to ₹200 Crores consisting of various types of NCDs. These NCDs are planned for listing on BSE Limited.
From equitybulls.com
Why it matters
The capital raise is intended to bolster the bank's capital adequacy under the Basel II framework. The specific NCDs are categorized as Lower Tier II Capital. This move is crucial for the bank to maintain its operational standing and regulatory compliance.
From equitybulls.com
Who's involved
- board of directorsThe board of directors approved the capital raising structure for the bank.
Who could feel it
Possible knock-on effectsThese are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.
- bankSpeculative
The bank could face increased financial obligations related to the issuance and management of the new capital structure.
How this reaches others
Each traced step by step, with the reporting behind itKeep exploring
The entities involved
-
board of directors
group of people who jointly supervise the activities of an organization
Related events
- Board of Directors of IIFL Finance Limited approved the allotment of Non-Convertible Debentures (NCD) on September 3, 2026.
- Natco Pharma's board of directors approved a major capital-raising plan on September 9, 2026.
- A company's board of directors approved an enhanced corporate and financing framework on July 24, 2026.
- Akme Fintrade approved the allotment of Non-Convertible Debentures (NCDs) and proposed them for listing on the National Stock Exchange of India (NSE).